Prevalence and risk factors for minimal hepatic encephalopathy in cirrhotic patients with different etiologies

Author:

Li Xiaoyan12ORCID,Liu Shanghao3,Xiang Huiling4,Zhang Qingge5,Guo Ying6,Zu Hongmei7,Wang Jing8,Lv Jiaojian9,Zhang Xiaoning2,Meng Fanping2,Li Jiahuan10,Li Jie11,Bianba Yangzhen12,Shang Jia13,Zhang Guo14,Liu Fei15,Tong Zhaowei16,Lei Chuang17,Ye Wei18,Yang Qiaohua19,Wang Ningning20,Song Ying21,Fu Wei22,Li Ziyue23,Gao Yanjing24ORCID,Zhang Yongping25,Chen Jiafang26,Wu Caiyun27,Zheng Qi28,Wang Fang29,Yu Jiali30,Lin Lianjie31,Yang Chuanlong32,Yang Xiaoting33,Ye Xiaomin34,Wang Xiangmei35,Zhao Xuelan36,Qi Xiaolong37ORCID,Wang Fusheng12,Fu Junliang138

Affiliation:

1. Medical School of Chinese PLA Beijing China

2. National Clinical Research Center for Infectious Diseases The Fifth Medical Center of Chinese PLA General Hospital Beijing China

3. The First School of Clinical Medicine of Lanzhou University Lanzhou Gansu China

4. Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Department of Gastroenterology and Hepatology, Tianjin Third Central Hospital Institute of Hepatobiliary Disease Tianjin China

5. Hepatology Department of Integrated Traditional Chinese and Western Medicine Xingtai People's Hospital Xingtai Hebei China

6. Department of Hepatology The Third people's Hospital of Taiyuan Taiyuan Shanxi China

7. Department of Gastroenterology The Fourth People's Hospital of Qinghai Province Xining Qinghai China

8. Department of Gastroenterology The Second Affiliated Hospital of Baotou Medical College Baotou Inner Mongonia China

9. Department of Infectious Disease Lishui City People's Hospital Lishui Zhejiang China

10. Department of Infectious Diseases, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei China

11. Department of Infectious Diseases, Nanjing Drum Tower Hospital, The Affiliated Hospital of Medical School Nanjing University Nanjing Jiangsu China

12. Department of Hepatology The Third People's Hospital of Tibet Autonomous Region Lhasa Xizang China

13. Department of Infectious Diseases Henan Provincial People's Hospital Zhengzhou Henan China

14. Department of Gastroenterology The People's Hospital of Guangxi Zhuang Autonomous Region Nanning Guangxi China

15. Hunan Key Laboratory of Viral Hepatitis, Department of Infectious Diseases, Xiangya Hospital Central South University Changsha Hunan China

16. Department of Infectious Diseases Huzhou Central Hospital Huzhou Zhejiang China

17. Department of Infectious Diseases  The First People's Hospital of Changde City Changde Hunan China

18. Liver Cirrhosis Treatment Center Nanjing Hospital Affiliated to Nanjing University of Traditional Chinese Medicine Nanjing Jiangsu China

19. Hepatology Department of Infectious Diseases Center The First People's Hospital of Huaihua Huaihua Hunan China

20. Department of Gastroenterology The First Hospital of China Medical University Shenyang Liaoning China

21. Department of Gastroenterology Xi'an GaoXin Hospital Xi'an Shaanxi China

22. Department of Hepatology Shenyang 739 Hospital Shenyang Liaoning China

23. Department of Infectious Diseases The Third Hospital of Hebei Medical University Shijiazhuang Hebei China

24. Department of Gastroenterology Qilu Hospital of Shandong University Jinan Shandong China

25. Department of Infectious Diseases People's Hospital of Xinjiang Uygur Autonomous Region Urumqi Xinjiang Uyghur Autonomous Region China

26. Department of Gastroenterology Datong City Fourth People's Hospital Datong Shanxi China

27. Department of Hepatology Third People′s Hospital of Linfen City Linfen Shanxi China

28. Department of Hepatology, Hepatology Research Institute, The First Affiliated Hospital Fujian Medical University Fuzhou Fujian China

29. Department of Hepatology, Shenzhen Third People's Hospital, National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital, School of Medicine Southern University of Science and Technology Shenzhen Guangdong China

30. Department of Gastroenterology The First Affiliated Hospital of Dalian Medical University Dalian Liaoning China

31. Shengjing Hospital of China Medical University Shenyang Liaoning China

32. Department of Severe Liver Disease Shandong Public Health Clinical Center Jinan Shandong China

33. Department of Gastroenterology Wuzhong People's Hospital Wuzhong Ningxia China

34. Department of Gastroenterology Xichang People's Hospital Liangshan Yi Autonomous Prefecture Sichuan China

35. Department of Severe Hepatology Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou Fujian China

36. Department of Gastroenterology Liver Diseases Chongqing Public Health Medical Center Chongqing China

37. Department of Radiology, Zhongda Hospital, Medical School, Center of Portal Hypertension Southeast University Nanjing Jiangsu China

38. Department of Infectious Diseases The Fifth Medical Center of Chinese PLA General Hospital Beijing China

Abstract

AbstractAimsMinimal hepatic encephalopathy (MHE) significantly affects the prognosis of patients with cirrhosis. This study was performed to determine whether there is a difference in the prevalence of MHE among patients with cirrhosis of different etiologies and whether the etiology directly influences the occurrence of MHE.MethodsThis multicenter, cross‐sectional study enrolled 1879 patients with confirmed cirrhosis at 40 hospitals from October 25, 2021, to January 10, 2023 (Trial registration: https://clinicaltrials.gov/[NCT05140837]). The patients' demographics, etiologies of cirrhosis, and laboratory test results were collected. The psychometric hepatic encephalopathy score (PHES) was determined in all patients to screen for MHE. Multivariate logistic analyses were performed to identify the risk factors for MHE.ResultsIn total, 736 patients with cirrhosis were analyzed. The prevalence of MHE was 42.0% (n = 309). The primary etiology among all patients was hepatitis B virus (HBV)‐related cirrhosis (71.9% [529/736]). The prevalence of MHE was significantly higher in patients with alcoholic cirrhosis (57.1% [40/70]) than in those with HBV‐related cirrhosis (40.6% [215/529], p = 0.009) or hepatitis C virus (HCV)‐related cirrhosis (38.2% [26/68], p = 0.026). Age (odds ratio [OR], 1.042; 95% confidence interval [CI], 1.024–1.059; p < 0.001), duration of education (OR, 0.935; 95% CI, 0.899–0.971; p = 0.001), etiology (OR, 1.740; 95% CI, 1.028–2.945; p = 0.039), and high MELD‐Na scores (OR, 1.038; 95% CI, 1.009–1.067; p = 0.009) were independent risk factors for MHE. When patients with cirrhosis of different etiologies were analyzed separately, the results showed that age (OR, 1.035; 95% CI, 1.014–1.057; p = 0.001) and duration of education (OR, 0.924; 95% CI, 0.883–0.966; p = 0.001) were risk factors for MHE among patients with HBV‐related cirrhosis, whereas age (OR, 1.138; 95% CI, 1.033–1.254; p = 0.009) and creatinine concentration (OR, 16.487; 95% CI, 1.113–244.160; p = 0.042) were risk factors for MHE in patients with HCV‐related cirrhosis. No risk factors for MHE were found in patients with autoimmune cirrhosis. For patients with alcoholic cirrhosis, the platelet count (OR, 1.014; 95% CI, 1.000–1.027; p = 0.045) was a risk factor for MHE. The PHES subtest results were inconsistent among patients who had MHE with cirrhosis of different etiologies. Patients with HBV‐related cirrhosis performed better on Number Connection Test B and the serial dotting test than those with alcoholic cirrhosis (p = 0.007 and p < 0.001), better on Number Connection Test B than those with HCV‐related cirrhosis (p = 0.020), and better on the line tracing test than those with autoimmune cirrhosis (p = 0.037).ConclusionThe etiology of cirrhosis affected the prevalence of MHE and risk factors for MHE. The domains of major cognitive impairment varied among patients with cirrhosis of different etiologies. Further studies are required to verify these findings.

Funder

National Natural Science Foundation of China

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3